Alvotech (ALVO) Other Accumulated Expenses (2020 - 2026)
Alvotech (ALVO) posted Other Accumulated Expenses of $92.3 million for Q1 2026, down 2.04% on a QoQ basis from $94.2 million in Q4 2025, and up 42.86% year-over-year from $64.6 million in Q1 2025.
Alvotech (ALVO) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Alvotech's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $92.3 million for Q1 2026.
- Quarterly Other Accumulated Expenses rose 42.86% year-over-year to $92.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $92.3 million (up 42.86% YoY) and the FY2025 annual result came in at $94.2 million, up 58.62% from the prior year.
- Other Accumulated Expenses was $92.3 million for Q1 2026 at Alvotech, down from $94.2 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $100.4 million in Q3 2025 and bottomed at $50.5 million in Q3 2024.
- A 5-year average of $72.7 million and a median of $70.0 million in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2024 — Other Accumulated Expenses slipped 27.1% — and 2025, when it jumped 98.72%.
- Alvotech's Other Accumulated Expenses stood at $54.0 million in 2022, then increased by 16.05% to $62.7 million in 2023, then slipped by 5.29% to $59.4 million in 2024, then jumped by 58.62% to $94.2 million in 2025, then fell by 2.04% to $92.3 million in 2026.
- Business Quant data shows ALVO's Other Accumulated Expenses at $92.3 million in Q1 2026, $94.2 million in Q4 2025, and $100.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Alvotech | 924.10 Mn | 924.10 Mn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.31 Mn |
| Dec 31, 2025 | 94.23 Mn |
| Sep 30, 2025 | 100.38 Mn |
| Jun 30, 2025 | 73.14 Mn |
| Mar 31, 2025 | 64.61 Mn |
| Dec 31, 2024 | 59.40 Mn |
| Sep 30, 2024 | 50.51 Mn |
| Jun 30, 2024 | 62.46 Mn |
| Mar 31, 2024 | 76.01 Mn |
| Dec 31, 2023 | 62.72 Mn |
| Jun 30, 2023 | 85.68 Mn |
| Mar 31, 2023 | 75.10 Mn |
| Dec 31, 2022 | 54.05 Mn |
| Jun 30, 2022 | 66.83 Mn |
| Dec 31, 2021 | 42.01 Mn |
| Dec 31, 2020 | 16.42 Mn |